Nkarta, Inc. (NKTX)
2.69
-0.07
(-2.54%)
USD |
NASDAQ |
Aug 31, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nkarta Free Cash Flow : -93.90M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -93.90M |
| March 31, 2026 | -88.39M |
| December 31, 2025 | -89.91M |
| September 30, 2025 | -93.55M |
| June 30, 2025 | -100.20M |
| March 31, 2025 | -105.55M |
| December 31, 2024 | -104.10M |
| September 30, 2024 | -108.41M |
| June 30, 2024 | -109.55M |
| March 31, 2024 | -117.41M |
| December 31, 2023 | -114.31M |
| September 30, 2023 | -126.52M |
| June 30, 2023 | -122.52M |
| March 31, 2023 | -109.66M |
| Date | Value |
|---|---|
| December 31, 2022 | -104.11M |
| September 30, 2022 | -80.41M |
| June 30, 2022 | -77.71M |
| March 31, 2022 | -77.30M |
| December 31, 2021 | -72.95M |
| September 30, 2021 | -68.21M |
| June 30, 2021 | -62.19M |
| March 31, 2021 | -56.08M |
| December 31, 2020 | -51.02M |
| September 30, 2020 | -44.35M |
| June 30, 2020 | -35.85M |
| March 31, 2020 | -26.66M |
| December 31, 2019 | -20.30M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Theriva Biologics, Inc. | -12.76M |
| Unicycive Therapeutics, Inc. | -27.85M |
| OnKure Therapeutics, Inc. | -47.86M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.22M |
| Cash from Investing (Quarterly) | 21.15M |
| Cash from Financing (Quarterly) | 0.676M |
| Free Cash Flow Per Share (Quarterly) | -0.3276 |
| Free Cash Flow to Equity (Quarterly) | -22.94M |
| Free Cash Flow to Firm (Quarterly) | -24.41M |
| Free Cash Flow Yield | -47.04% |